FOSTER
CITY, Calif., July 18,
2024 /PRNewswire/ -- MedGenome, a leading provider
of multiomics solutions, today announced the acquisition of a
PacBio Revio sequencing system. This latest addition to MedGenome's
technology portfolio will significantly bolster their long-read
sequencing capabilities, enabling researchers to delve deeper into
the complexities of the genome and advance scientific
discoveries.
PacBio's platforms are known for their ability to deliver highly
accurate long-read sequencing data, providing crucial insights into
complex genomic regions previously inaccessible with short-read
technologies. This acquisition allows MedGenome to offer end-to-end
solutions for applications including:
- Improved genome assembly: Generating complete and
contiguous de novo genome assemblies, even for
organisms with complex genomes.
- Enhanced transcriptome profiling: Uncovering novel
transcripts and isoforms, providing a more detailed view of gene
expression, even down to the single-cell level.
- Comprehensive variant detection: Detecting a wider range of
genetic variations, including structural variants and repeat
expansions for understanding diseases, including cancer.
This announcement comes on the heels of MedGenome's recent SMRT
Grant award to sequence the genome of the Dune Scorpion in
collaboration with PacBio and the California Academy of Sciences.
The project highlights the growing demand for highly accurate
long-read sequencing in biodiversity studies, and the Revio system
will play a key role in enabling such research.
"We are excited to add the PacBio Revio system to our suite of
cutting-edge genomic technologies," said Dr. Felix Olale, Chairman of the Board at MedGenome.
"This investment underscores our commitment to providing
researchers with the most advanced end-to-end solutions to drive
groundbreaking discoveries in healthcare, personalized medicine,
and beyond."
"We're thrilled to partner with MedGenome as the first
commercial service provider in the San
Francisco Bay Area of California to offer Revio's advanced long-read
sequencing capabilities in-house," said Jeff Eidel, Chief Commercial Officer at PacBio.
"Their commitment to advancing scientific discovery aligns
perfectly with our mission at PacBio, and we're confident that this
collaboration will empower researchers with the tools they need to
make groundbreaking discoveries."
This acquisition further solidifies MedGenome's position as a
leader in the multiomics solutions industry. MedGenome's extensive
expertise across multiomics workflows enables them to push the
envelope on clients' research and provide project consultation,
bundled assays for robust experimentation, and deep analysis
capabilities to bring insights from data. By integrating the PacBio
Revio system with their existing portfolio of next-generation
sequencing (NGS), bioinformatics, and data analytics platforms,
MedGenome offers a comprehensive and powerful solution for
researchers seeking to unravel the complexities of the genome and
accelerate scientific breakthroughs.
About MedGenome:
MedGenome is a genomics-driven research and
diagnostics company devoted to improving global health by
decoding the genetic information contained in an individual's
genome. As a global partner for comprehensive multiomics solutions,
MedGenome helps advance precision medicine that can reduce
healthcare disparities and improve patient outcomes. Our unique
access to the world's most diverse genomic database and deep
scientific expertise enables researchers to accelerate their
research, find cost efficiencies, and bring drugs to market faster.
MedGenome is backed by a global investor base
spanning Europe, Asia, and Africa, including support
from Novo Holdings, one of the world's leading life sciences
investors. MedGenome's high-throughput next-generation sequencing
lab is in Foster City, California. Follow us
on LinkedIn.
Logo:
https://mma.prnewswire.com/media/2402832/MedGenome_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/medgenome-boosts-omic-insights-capabilities-as-the-first-commercial-provider-in-the-san-francisco-bay-area-of-california-to-bring-pacbio-revio-in-house-with-full-service-capability-302200570.html
SOURCE MedGenome